Trump signs order to test US ‘payment model’ for some medicines – By Riley Griffin and Josh Wingrove (Bloomberg) / Sept 14 2020
The US president says at a campaign rally that ‘the cost of prescription drugs will be dropping like a rock very soon’
President Donald Trump started a process that could cut some U.S. drug costs by tying prices to those paid by countries with national health systems, a move drugmakers said will stifle innovation.
The order, released on Sunday, came after an earlier attempt to force pharmaceutical companies to make reductions didn’t yield results.
Trump, while on a campaign swing to Nevada, tweeted that he’d signed an order on the “most favored nation” plan, which would try to link Medicare Part B and Part D prices to lower prices paid by other countries. The approach was broader than an initial effort that only targeted Part B.
The order is a first step that instructs the U.S. Department of Health and Human Services to begin the rule-making process to test “a payment model” for some medicines. It offered few details.
Continue to article: https://www.aljazeera.com/ajimpact/trump-signs-order-test-payment-model-medicines-200914041425802.html
